Red light and the sleep quality and endurance performance of Chinese female basketball players.
Context: Good sleep is an important recovery method for prevention
and treatment of overtraining in sport practice. Whether sleep is
regulated by melatonin after red-light irradiation in athletes is
Objective: To determine the effect of red light on sleep quality and endurance performance of Chinese female basketball players.
Design: Cohort study.
Setting: Athletic training facility of the Chinese People's Liberation Army and research laboratory of the China Institute of Sport Science.
Patients or Other Participants: Twenty athletes of the Chinese People's Liberation Army team (age = 18.60 [+ or -] 3.60 years) took part in the study. Participants were divided into redlight treatment (n = 10) and placebo (n = 10) groups.
Intervention(s): The red-light treatment participants received 30 minutes of irradiation from a red-light therapy instrument every night for 14 days. The placebo group did not receive light illumination.
Main Outcome Measure(s): The Pittsburgh Sleep Quality Index (PSQI) questionnaire was completed, serum melatonin was assessed, and 12-minute run was performed at preintervention (baseline) and postintervention (14 days).
Results: The 14-day whole-body irradiation with red-light treatment improved the sleep, serum melatonin level, and endurance performance of the elite female basketball players (P < .05). We found a correlation between changes in global Pittsburgh Sleep Quality Index and serum melatonin levels (r = -0.695, P = .006).
Conclusions: Our study confirmed the effectiveness of body irradiation with red light in improving the quality of sleep of elite female basketball players and offered a nonpharmacologic and noninvasive therapy to prevent sleep disorders after training.
Key Words: Pittsburgh Sleep Quality Index, melatonin, 12-minute run
Sleep (Health aspects)
Light (Health aspects)
Women basketball players (Physiological aspects)
Women basketball players (Health aspects)
Athletic ability (Research)
|Publication:||Name: Journal of Athletic Training Publisher: National Athletic Trainers' Association, Inc. Audience: Academic Format: Magazine/Journal Subject: Sports and fitness Copyright: COPYRIGHT 2012 National Athletic Trainers' Association, Inc. ISSN: 1062-6050|
|Issue:||Date: Nov-Dec, 2012 Source Volume: 47 Source Issue: 6|
|Topic:||Event Code: 310 Science & research|
|Geographic:||Geographic Scope: China Geographic Code: 9CHIN China|
Good sleep is a prerequisite for optimal performance. (1) Given
that people spend about one-third of their lives asleep, sleep has
substantial functions for development, daily functioning, and health.
(2) Perhaps no daytime behavior has been associated more closely with
improved sleep than exercise. (3) Researchers have shown that exercise
serves as a positive function for sleep. Regular exercise consistently
has been associated with better sleep. (4) Moreover, the American
Academy of Sleep Medicine considers physical exercise to be a modality
of nonpharmacologic treatment for sleep disorders. (4) When studying the
influence of exercise on sleep, most investigators have compared acute
exercise and sedentary control treatments. (5) In their study of chronic
moderate-intensity endurance exercise, Driver and Taylor (6) also
provided compelling evidence that exercise promotes sleep.
However, exercise can negatively affect sleep quality. Exercising immediately before going to sleep is detrimental to sleep quality. (7) Athletes train very hard to improve their on-field performances, but excessive training may lead to a decrease in performance, which is known as overtraining syndrome. Researchers (8) have shown that symptoms of overtraining indicate poor-quality sleep. Good sleep is an important recovery method for prevention and treatment of overtraining in sport practice. (9)
Evidence is compelling that chronic exposure to bright light (3000 lux) can enhance sleep. (10) Guilleminault et al (11) suggested that the effects of exposure to light may be more powerful than those associated with exercise. In a recent study in which red-light therapy (wavelength = 670 nm, light dose = 4 J/[cm.sup.2]) was used, Yeager et al (12) indicated that red light could restore glutathione redox balance upon toxicologic insult and enhance both cytochrome c oxidase and energy production, all of which may be affected by melatonin. Melatonin is a neurohormone that is produced by the pineal gland and regulates sleep and circadian functions. (13) No one knows whether sleep is regulated by melatonin after red-light irradiation in athletes. Researchers (14,15) have demonstrated that phototherapy improves muscle regeneration after exercise. Red light could protect human erythrocytes in preserved diluted whole blood from the damage caused by experimental artificial heart-lung machines. (16) However, the effect of red-light illumination on endurance performance is a new topic in sport science.
Sleep quality can be defined subjectively by self-report (17) or by more objective measures, such as polysomnography or actigraphy. (18) Subjective sleep quality has been assessed most widely with the Pittsburgh Sleep Quality Index (PSQI). (17) The PSQI is a comprehensive 18-item self-report questionnaire assessing sleep disturbances in the previous month. It derives ordinal scores for 7 clinically relevant domains of sleep: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances (eg, awakenings from sleep due to discomfort, bad dreams), use of sleeping medication, and daytime dysfunction (feeling sleepy during the day due to a poor night's sleep). Scores from these separate components are combined to derive a global measure of sleep quality. (19)
As demonstrated in these studies, acute or chronic exercise may lead to good- or bad-quality sleep. However, the effects of red light on sleep quality and endurance performance have not been investigated sufficiently. Therefore, the purpose of our study was to determine the effect of red light on the sleep quality and endurance performance of Chinese female basketball players.
Twenty female athletes of the Chinese People's Liberation Army team (age = 18.60 [+ or -] 3.60 years) participated in the study. Participant characteristics are described in Table 1. All participants were healthy and were not using medications regularly or temporarily during the measurements. Athletes were excluded if they had participated in less than 80% of the scheduled team physical training and basketball sessions for the last 3 months or used any kind of nutritional supplements or pharmacologic agents. All participants provided written informed consent, and the study was approved by the Ethical Committee of the China Institute of Sport Science.
We used a randomized parallel pretest-posttest design. Participants were assigned randomly to either a red-light therapy intervention group (n = 10) or non-red-light therapy intervention group (placebo group, n = 10). Measurements were collected at preintervention (baseline) and postintervention (14 days). The exercise training schedule of the 2 groups was unchanged during the 14 days; the red-light treatment group used a red-light therapy instrument every night for total body irradiation for 30 minutes. The training routine of the athletes during the 14 intervention days included 12 exercise sessions with the following specifications: 2 hours of morning training, 2 hours of afternoon training, and no training on Sunday.
[FIGURE 1 OMITTED]
The red-light treatment participants lay in the supine position, and continuous illumination was performed using noncoherent red light from a whole-body red-light treatment machine (Shanghai Dayou PDT Technology Co, Ltd, Shanghai, China) with an average wavelength of 658 nm and light dose of 30 J/[cm.sup.2]. The whole body received the phototherapy treatment (Figure 1). In general studies, investigators have used 14 days (20,21) or 7 days (22) as 1 session period, so we chose 14 days as a trial time. The placebo participants also lay in the supine position under the red-light device but did not receive any light illumination. All participants wore swimsuits to enhance irradiation from the device and were blind to the treatment.
Sleep Quality. Sleep quality was measured by the Chinese version of the PSQI. (17) The 19-item measure assesses sleep quality and disturbances over a half-month time interval. The total PSQI score ranges from 0 to 21, and higher scores reflect poorer-quality sleep. (17) The 7 items of this instrument measure several aspects of insomnia: difficulties with onset and maintenance of sleep, satisfaction with the current sleep pattern, interference with daily functioning, noticeable impairment attributed to sleep problems, degree of distress, and concern caused by any sleeping problems.
Cooper 12-Minute Run. Participants were instructed to complete as many laps as possible on a 400-m outdoor track during the 12-minute test period. Emphasis was placed on pacing oneself throughout the test. The test administrators (J.Z., D.L., and J.X.) counted the laps completed during the 12-minute test period while calling out the time elapsed at 3, 6, and 9 minutes and orally encouraging the participants. At the end of the 12-minute period, the test administrator instructed the participants to stop and used a measuring wheel to determine the fraction of the last lap completed by each participant. This distance was added to the distance determined by the number of laps completed to give the total distance covered during the test.
[FIGURE 2 OMITTED]
Serum Melatonin. In humans, the serum level of melatonin, which is derived mainly from the pineal gland, demonstrates a clear increase at night and a decrease during the day. (23,24) Given that the masking effects of activities (eg, exercise, sleep, and food intake (25,26)) have little effect on the daily pattern of the circulating melatonin level, melatonin secretion appears to directly reflect the function of the biological clock as a specific marker of circadian rhythm. (27) We drew blood samples in the morning (8:00 AM) of preintervention and postintervention. Melatonin in the serum was measured in pictograms per milliliter using an enzyme-linked immunosorbent assay kit (Melatonin ELISA; IBL, Hamburg, Germany).
Data were analyzed using descriptive statistics, 2-way analyses of variance (ANOVAs), and t tests for independent means. Isolated comparisons between groups (experimental, control) and times (preintervention, postintervention) were performed only in cases where time x group interactions were found. We used Pearson product moment correlation coefficients to determine the relationships among sleep quality, serum melatonin, and endurance performance. The [alpha] level was set at .05. We used SPSS (version 16.0; IBM Corporation, Armonk, NY) for data analysis.
We found no differences in any of the baseline characteristics between the groups.
We found an effect for group ([F.sub.1,18] = 5.62, P = .03) and a time x group interaction for global PSQI scores ([F.sub.1,18] = 5.66, P = .03; Figure 2). At preintervention, we found no difference between the groups ([t.sub.18] = -0.53, P = .60). At postintervention, participants in the red-light treatment group demonstrated greater improvement in global PSQI scores than the placebo group ([t.sub.18] = -4.55, P < .001). Descriptive statistics and statistical values for the PSQI subscores are listed in Table 2. Among the subscores, we found a time x group interaction for subjective sleep quality ([F.sub.1,18] = 6.70, P = .02) and effects of group for sleep duration ([F.sub.1,18] = 5.36, P = .03) and sleep latency ([F.sub.1,18] = 5.65, P = .03). We noted an effect of time for daytime dysfunction ([F.sub.1,18] = 6.40, P = .02). We did not observe an effect of group or a time x group interaction for habitual sleep efficiency ([F.sub.1,18] = 2.49, P = .13 and [F.sub.1,18] = 2.84, P = .11, respectively) or sleep disturbance ([F.sub.1,18] = 0.21, P = .65 and [F.sub.1,18] = 3.32, P = .09, respectively) variables.
We found an effect for group ([F.sub.1,18] = 18.84, P < .00l) and a time x group interaction for serum melatonin level ([F.sub.1,18] = 14.08, P = .001). At preintervention, we demonstrated no difference between the red-light treatment (22.2 [+ or -] 7.2 pg/mL) and placebo (21.7 [+ or -] 6.8 pg/mL) groups ([t.sub.18] = 0.17, P = .87). At postintervention, participants in the red-light treatment group (38.8 [+ or -] 6.7 pg/mL) demonstrated greater improvement in serum melatonin level than the placebo group (23.8 [+ or -] 7.3 pg/ mL; [t.sub.18] = 4.96, P < .001; Figure 3).
We noted an effect of time for distance ([F.sub.1,18] = 12.76, P = .004). We observed a trend toward improvement but no time x group interaction ([F.sub.1,18] = 1.72, P = .22). A difference was found between preintervention and postintervention of the red-light treatment group ([t.sub.18] = 3.54, P = .005; Figure 4).
[FIGURE 3 OMITTED]
Relationship Among Improvements in Sleep Quality, Serum Melatonin Level, and Endurance Performance
We demonstrated a correlation between changes in global PSQI and serum melatonin levels (r = -0.695, P = .006; Table 3). We also saw a trend toward a negative relationship between change in global PSQI and distance of the 12-minute run test at preintervention and postintervention for all participants (r = -0.353, P = .07; Table 3). In addition, when the results of the postintervention were analyzed alone, we found a negative correlation between change in the distance of the 12-minute run test and global PSQI (r = -0.579, P = .02).
Our results indicated that a 14-day program of red-light treatment improved sleep and serum melatonin levels. Although the statistical analysis did not reveal differences between groups for running distance in the aerobic exercise test, the percentage increase in the red-light treatment group (12.8%) was higher than the percentage increase in the control group (5.5%; P < .05).
[FIGURE 4 OMITTED]
The PSQI revealed that the improvements in global PSQI scores and sleep quality were greater at postintervention in the red-light treatment group than in the placebo group. In addition, we found an effect of time for daytime dysfunction ([F.sub.1,8] = 6.40, P = .02). Sack et al (28) suggested a role of melatonin in facilitating sleepiness during the night by inhibiting a central nervous system wakefulness-generating system. The positive effect seen m our study may be due to relatively higher melatonin levels after the red-light illumination. Our results are in accordance with those reported in previous studies, showing that melatonin might be a principal component of red-light therapy. (12) In their analysis of the effects of light on melatonin levels and rhythms in humans, Wright and Lack (29) showed that, whereas shorter wavelengths of blue (430 nm) and green (540 nm) light suppress salivary melatonin and shift the melatonin rhythm, red light (610 nm and 660 nm) has no effect on melatonin suppression and slightly shortens the time before dim-light onset of melatonin secretion. Recently, Figueiro and Rea (22) demonstrated that blue light reduced nocturnal levels of melatonin, whereas red light increased them. However, our observations contradicted those reported in studies of adults with insomnia in which researchers (30) reported negative relationships between the red-light condition and improved sleep variables and daytime symptoms. Conflicting results in the literature may stem from studying different participants. In our study, the participants were female basketball players who did not have severe insomnia.
We observed an effect of time on distance ([F.sub.1,8] = 12.76, P = .004), such that 12-minute run distance was longer after 14 days of red-light illumination in basketball players. For the 12-minute run distance, an effect was noted for time but not for group; no time x group interaction was seen. Therefore, we could not draw a clear conclusion that redlight illumination induced positive changes in endurance performance among basketball players. With regard to the association of red light and exercise, the data are quite scarce. As far as we know, only 1 study (31) of red light and exercise in human participants has been published. The study was carried out in healthy, physically active male volunteers, and treatment with light-emitting diodes produced a smaller decrease in maximal isometric torque after high-intensity concentric isokinetic exercise. Ihsan (32) demonstrated that laser promoted arteriolar vasodilation and improved the peripheral microcirculation. In addition, phototherapy could improve the muscle regeneration after exercise. (33) Therefore, observations by us and by Baroni et al (31) may be mainly related to increased arteriolar vasodilation and peripheral microcirculation after red-light illumination.
We found a correlation between changes in global PSQI and serum melatonin levels (r = -0.695, P = .006). A negative relationship existed between decreases in sleep quality and improvements in endurance performance as determined by 12-minute run distance, but this was only a trend (r = -0.353, P = .07). We also demonstrated a correlation between sleep quality and distance of the 12-minute run test during the postintervention period. This in part may be due to sleep providing recovery from autonomic reactivity, psychoemotional tension, and hormonal responses. (34) These results suggest that endurance performance was mediated by mechanisms other than sleep quality alone.
We have demonstrated that red-light illumination positively affected sleep quality and endurance performance variables in Chinese female basketball players. Based on previous studies, (6,12,14,15,33) we can infer that red-light treatment contributes to increased melatonin secretion in the pineal gland and muscle regeneration. To our knowledge, we are the first to demonstrate the positive effects of red-light treatment on sleep and aerobic performance, which is an interesting link with practical application to sports training. Although more studies involving phototherapy, sleep, and exercise performance need to be performed, red-light treatment is a possible nonpharmacologic and noninvasive therapy to prevent sleep disorders after training.
* Red-light illumination positively affected sleep quality and endurance performance variables in Chinese female basketball players.
* Red-light illumination is a positive nonpharmacologic and noninvasive therapy to prevent sleep disorders after training.
This research project was supported by National Key Technologies R&D Program Fund of China (2006BAK37B06).
We thank Professor Craig G. Crandall for editing and Dr James Pearson for proofreading the manuscript. We also thank Bin Fan and Qingde Shi for analyzing and entering the data; Baoxin Feng, Peifang Zong, Wenyuan Shang, Weiying Zhang, and Pengfei Li for their technical assistance; and our volunteers for their willingness to participate in this project.
(1.) Skein M, Duffield R, Edge J, Short MJ, Mundel T. Intermittent-sprint performance and muscle glycogen after 30 h of sleep deprivation. Med Sci Sports Exerc. 2011;43(7):1301-1311.
(2.) Gerber M, Brand S, Holsboer-Trachsler E, Puhse U. Fitness and exercise as correlates of sleep complaints: is it all in our minds? Med Sci Sports Exerc. 2010;42(5):893-901.
(3.) Youngstedt SD. Effects of exercise on sleep. Clin Sports Med. 2005;24(2):355-365, xi.
(4.) Myllymaki T, Kyrolainen H, Savolainen K, et al. Effects of vigorous late-night exercise on sleep quality and cardiac autonomic activity. J Sleep Res. 2011;20(1 pt 2):146-153.
(5.) Youngstedt SD, Kripke DF, Elliott JA. Is sleep disturbed by vigorous late-night exercise? Med Sci Sports Exerc. 1999;31(6):864-869.
(6.) Driver HS, Taylor SR. Exercise and sleep. Sleep Med Rev. 2000;4(4):387-402.
(7.) van Straten A, Cuijpers P. Self-help therapy for insomnia: a metaanalysis. Sleep Med Rev. 2009;13(1):61-71.
(8.) Tanskanen M, Atalay M, Uusitalo A. Altered oxidative stress in overtrained athletes. J Sports Sci. 2010;28(3):309-317.
(9.) Roose J, de Vries WR, Schmikli SL, Backx FJ, van Doornen LJ. Evaluation and opportunities in overtraining approaches. Res Q Exerc Sport. 2009;80(4):756-764.
(10.) Campbell SS, Dawson D, Anderson MW. Alleviation of sleep maintenance insomnia with timed exposure to bright light. J Am Geriatr Soc. 1993;41(8):829-836.
(11.) Guilleminault C, Clerk A, Black J, Labanowski M, Pelayo R, Claman D. Nondrug treatment trials in psychophysiologic insomnia. Arch Intern Med. 1995;155(8):838-844.
(12.) Yeager RL, Oleske DA, Sanders RA, Watkins JB III, Eells JT, Henshel DS. Melatonin as a principal component of red light therapy. Med Hypotheses. 2007;69(2):372-376.
(13.) Radogna F, Diederich M, Ghibelli L. Melatonin: a pleiotropic molecule regulating inflammation. Biochem Pharmacol. 2010; 80(12):1844-1852.
(14.) Leal Junior EC, Lopes-Martins RA, Rossi RP, et al. Effect of cluster multi-diode light emitting diode therapy (LEDT) on exercise-induced skeletal muscle fatigue and skeletal muscle recovery in humans. Lasers Surg Med. 2009;41 (8):572-577.
(15.) Leal Junior EC, Lopes-Martins RA, Baroni BM, et al. Comparison between single-diode low-level laser therapy (LLLT) and LED multidiode (cluster) therapy (LEDT) applications before high-intensity exercise. Photomed Laser Surg. 2009;27(4):617-623.
(16.) Itoh T, Murakami H, Orihashi K, et al. Low power laser protects human erythrocytes in an in vitro model of artificial heart-lung machines. Artif Organs. 2000;24(11):870-873.
(17.) Buysse DJ, Reynolds CF III, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193-213.
(18.) Buysse DJ, Ancoli-Israel S, Edinger JD, Lichstein KL, Morin CM. Recommendations for a standard research assessment of insomnia. Sleep. 2006;29(9):1155-1173.
(19.) Barclay NL, Eley TC, Buysse DJ, Rijsdijk FV, Gregory AM. Genetic and environmental influences on different components of the Pittsburgh Sleep Quality Index and their overlap. Sleep. 2010;33(5):659-668.
(20.) Desmet KD, Paz DA, Corry JJ, et al. Clinical and experimental applications of NIR-LED photobiomodulation. Photomed Laser Surg. 2006;24(2):121-128.
(21.) Whelan HT, Connelly JF, Hodgson BD, et al. NASA light-emitting diodes for the prevention of oral mucositis in pediatric bone marrow transplant patients. J Clin Laser Med Surg. 2002;20(6):319-324.
(22.) Figueiro MG, Rea MS. The effects of red and blue lights on circadian variations in cortisol, alpha amylase, and melatonin. Int J Endocrinol. 2010;2010:829351.
(23.) Lynch HJ, Wurtman RJ, Moskowitz MA, Archer MC, Ho MH. Daily rhythm in human urinary melatonin. Science. 1975;187(4172):169-171.
(24.) Miles A, Philbrick DR. Melatonin and psychiatry. Biol Psychiatry. 1988;23(4):405-425.
(25.) Lynch HJ, Jimerson DC, Ozaki Y, Post RM, Bunney WE Jr, Wurtman RJ. Entrainment of rhythmic melatonin secretion in man to a 12-hour phase shift in the light/dark cycle. Life Sci. 1978; 23(15):1557-1563.
(26.) Vaughan GM, Allen JP, Tullis W, Siler-Khodr TM, de la Pena A, Sackman JW. Overnight plasma profiles of melatonin and certain adenohypophyseal hormones in men. J Clin Endocrinol Metab. 1978;47(3):566-571.
(27.) Gastel JA, Roseboom PH, Rinaldi PA, Weller JL, Klein DC. Melatonin production: proteasomal proteolysis in serotonin Nacetyltransferase regulation. Science. 1998;279(5355):1358-1360.
(28.) Sack RL, Hughes RJ, Edgar DM, Lewy AJ. Sleep-promoting effects of melatonin: at what dose, in whom, under what conditions, and by what mechanisms? Sleep. 1997;20(10):908-915.
(29.) Wright HR, Lack LC. Effect of light wavelength on suppression and phase delay of the melatonin rhythm. Chronobiol Int. 2001; 18(5):801-808.
(30.) Lack L, Wright H, Kemp K, Gibbon S. The treatment of early-morning awakening insomnia with 2 evenings of bright light. Sleep. 2005;28(5):616-623.
(31.) Baroni BM, Leal Junior EC, Geremia JM, Diefenthaeler F, Vaz MA. Effect of light-emitting diodes therapy (LEDT) on knee extensor muscle fatigue. Photomed Laser Surg. 2010;28(5):653-658.
(32.) Ihsan FR. Low-level laser therapy accelerates collateral circulation and enhances microcirculation. Photomed Laser Surg. 2005;23(3):289-294.
(33.) Baroni BM, Leal Junior EC, De Marchi T, Lopes AL, Salvador M, Vaz MA. Low level laser therapy before eccentric exercise reduces muscle damage markers in humans. Eur J Appl Physiol. 2010;110(4):789-796.
(34.) Hynynen E, Uusitalo A, Konttinen N, Rusko H. Heart rate variability during night sleep and after awakening in overtrained athletes. Med Sci Sports Exerc. 2006;38(2):313-317.
Jiexiu Zhao, PhD *; Ye Tian, PhD *; Jinlei Nie, PhD ([dagger]); Jincheng Xu, MSS ([double dagger]); Dongsen Liu, MS ([double dagger])
* Sport Biological Center, China Institute of Sport Science, Beijing, China; ([dagger]) Department of Kinesiology, Macao Polytechnic Institute, China; ([double dagger]) Department of Kinesiology, Beijing Sport University, China
Address correspondence to Jieziu Zhao, PhD, Sport Biological Center, China Institute of Sport Science, No. 11 Tiyuguan Road, Dongcheng District, Beijing, China 100061. Address e-mail to firstname.lastname@example.org and email@example.com.
Table 1. Baseline Characteristics of the Participants (Mean [+ or -] SD) Treatment Group Variable Red Light Placebo Age, y 19.30 [+ or -] 4.30 17.90 [+ or -] 2.81 Maximal oxygen 48.88 [+ or -] 3.86 47.84 [+ or -] 2.51 consumption, mL x [kg.sup.-1] x [min.sup.-1] Height, m 1.83 [+ or -] 6.09 1.83 [+ or -] 5.68 Mass, kg 71.24 [+ or -] 8.26 70.75 [+ or -] 6.71 Body mass index 21.08 [+ or -] 1.84 21.37 [+ or -] 2.33 Table 2. Subjective Sleep Quality (Mean [+ or -] SD) Treatment Group Red Light Pittsburgh Sleep Quality Index Subscores (a) Preintervention Postintervention Sleep quality 1.80 [+ or -] 0.92 1.30 [+ or -] 0.48 Sleep latency 1.80 [+ or -] 1.03 0.30 [+ or -] 0.48 Sleep duration 0.30 [+ or -] 0.48 0.30 [+ or -] 0.48 Habitual sleep efficiency 0.90 [+ or -] 0.57 0.40 [+ or -] 0.52 Sleep disturbance 1.50 [+ or -] 0.97 0.90 [+ or -] 0.74 Use of sleeping medications 0.00 [+ or -] 0.00 0.00 [+ or -] 0.00 Daytime dysfunction 6.60 [+ or -] 3.53 1.20 [+ or -] 0.63 Treatment Group Placebo Pittsburgh Sleep Quality Index Subscores (a) Preintervention Postintervention Sleep quality 1.90 [+ or -] 0.74 2.20 [+ or -] 0.63 Sleep latency 0.70 [+ or -] 0.48 0.80 [+ or -] 0.42 Sleep duration 0.70 [+ or -] 0.48 0.90 [+ or -] 0.57 Habitual sleep efficiency 0.90 [+ or -] 0.57 1.00 [+ or -] 0.67 Sleep disturbance 1.30 [+ or -] 0.95 1.40 [+ or -] 0.70 Use of sleeping medications 0.00 [+ or -] 0.00 0.00 [+ or -] 0.00 Daytime dysfunction 2.00 [+ or -] 0.82 1.90 [+ or -] 0.74 Time Pittsburgh Sleep Quality Index Subscores (a) [F.sub.1,18] P Sleep quality 0.42 .53 Sleep latency 0.31 .58 Sleep duration 2.25 .15 Habitual sleep efficiency 1.26 .28 Sleep disturbance 1.69 .21 Use of sleeping medications NA NA Daytime dysfunction 6.40 .02 Time x Group Pittsburgh Sleep Quality Index Subscores (a) [F.sub.1,18] P Sleep quality 6.70 .02 Sleep latency 0.31 .58 Sleep duration 2.25 .15 Habitual sleep efficiency 2.84 .11 Sleep disturbance 3.32 .09 Use of sleeping medications NA NA Daytime dysfunction 3.60 .07 Group Pittsburgh Sleep Quality Index Subscores (a) [F.sub.1,18] P Sleep quality 3.24 .09 Sleep latency 5.65 .03 Sleep duration 5.36 .03 Habitual sleep efficiency 2.49 .13 Sleep disturbance 0.21 .65 Use of sleeping medications NA NA Daytime dysfunction 2.15 .16 Abbreviation: NA, not applicable. (a) Higher scores reflect worse sleep quality. Table 3. Relationships Among Improvements in Global Pittsburgh Sleep Quality Index, Serum Melatonin, and Endurance Performance Measurement r P Serum melatonin, pg/mL -0.695 (a) .006 12-min run test, m -0.353 .07 (a) Indicates difference (P < .01).
|Gale Copyright:||Copyright 2012 Gale, Cengage Learning. All rights reserved.|